EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Nodule Dye‐Localization Using Interventional Fluoroscopy for Image‐Guided Sublobar Lung Resection

Yueh‐Lin Wu, Kam‐Hong Kam, Chi‐Yen Liang, Yu‐Ting Lai, Tien‐Hsin Jeng, Chang‐Ching Lee, Ya‐Fen Wu, Yung‐Cheng Yang, Hsin‐Yi Yang, Jia‐Ming Chang

Thoracic Cancer · 2026-10 · 17 (20)

DOI: 10.1111/1759-7714.70401 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background Precise localization is critical for sublobar resection of small pulmonary nodules. We evaluated the safety, technical efficiency, and clinical outcomes of preoperative percutaneous dye‐localization using a cone‐beam computed tomography (CBCT)‐enabled flat‐panel detector interventional fluoroscopy system in a hybrid operating room (HOR). Methods We retrospectively reviewed 74 consecutive patients (137 lesions) who underwent image‐guided localization followed by video‐assisted thoracoscopic surgery (VATS) sublobar resection (wedge resection or segmentectomy) between 2022 and 2023 at Chia‐Yi Christian Hospital. Procedural workflow, localization success, surgical margins, and perioperative outcomes were systematically analyzed. Results Technical localization success was achieved in 100% of lesions (mean nodule diameter: 8.59 ± 4.85 mm). The procedure required a mean of 1.31 ± 0.67 puncture attempts per lesion at a mean depth of 5.22 ± 1.86 cm. Procedure‐related pneumothorax occurred in 29.7% (22/74) of patients, with 14.9% (11/74) requiring pigtail catheter drainage; pneumothorax occurrence was significantly associated with multiple puncture attempts ( p < 0.001) and lower‐lobe lesions ( p = 0.001). Lower‐lobe location was significantly associated with requiring more puncture attempts ( p = 0.028). For malignant lesions, the mean pathological resection margin was 17.16 ± 8.73 mm, with 92.31% achieving a margin‐to‐tumor ratio (MTR) ≥ 1. The mean postoperative hospital stay was 3.04 ± 1.16 days. Conclusions Single‐stage image‐guided dye‐localization and VATS sublobar lung resection in an HOR using a biplane CBCT‐enabled platform is safe, feasible, and effective. This streamlined workflow ensures high technical success and adequate surgical margins with manageable complications. Further studies are warranted to evaluate long‐term oncological outcomes.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →